TFDA-2024-0051-V251

Type IB variation for application TFDA-2024-0051. Type IB variation: Formulation Change for Infectivir — minor update

Variation Number
TFDA-2024-0051-V251
Type
Type IB
Application
TFDA-2024-0051
Change
CHG-2022-0251
Status
Pending
Fee
€4,804
Submitted
2023-12-15
Approved
—
Description

Type IB variation: Formulation Change for Infectivir — minor update